Compare ANAB & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANAB | CAL |
|---|---|---|
| Founded | 2005 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 382.4M |
| IPO Year | 2017 | N/A |
| Metric | ANAB | CAL |
|---|---|---|
| Price | $44.88 | $13.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | ★ $61.40 | $14.00 |
| AVG Volume (30 Days) | 560.8K | ★ 1.2M |
| Earning Date | 11-04-2025 | 12-09-2025 |
| Dividend Yield | N/A | ★ 2.10% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | $169,467,000.00 | ★ $2,702,018,000.00 |
| Revenue This Year | $135.45 | $1.74 |
| Revenue Next Year | N/A | $5.85 |
| P/E Ratio | ★ N/A | $21.55 |
| Revenue Growth | ★ 196.42 | N/A |
| 52 Week Low | $12.21 | $9.54 |
| 52 Week High | $47.86 | $27.11 |
| Indicator | ANAB | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 67.45 | 58.80 |
| Support Level | $42.80 | $11.09 |
| Resistance Level | $47.86 | $13.54 |
| Average True Range (ATR) | 2.40 | 0.77 |
| MACD | 0.14 | 0.20 |
| Stochastic Oscillator | 65.87 | 81.61 |
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.